Akanda Corp. (AKAN)
2.63
+0.18
(+7.48%)
USD |
NASDAQ |
Jan 12, 16:00
2.82
+0.19
(+7.22%)
After-Hours: 05:20
Akanda Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alterola Biotech, Inc. | 0.017M |
| Kiniksa Pharmaceuticals International Plc | 24.14M |
| Aditxt, Inc. | 0.672M |
| Iovance Biotherapeutics, Inc. | 75.17M |
| Travere Therapeutics, Inc. | 51.89M |